Brief: Amicus Therapeutics Receives Positive CHMP Opinion For Opfolda® (Miglustat) For Late-Onset Pompe Disease

Amicus Therapeutics

26/04/2023 18:23

April 26 (Reuters) - Amicus Therapeutics Inc  FOLD.O :
    * AMICUS THERAPEUTICS RECEIVES POSITIVE CHMP OPINION FOR
OPFOLDA®
(MIGLUSTAT) FOR LATE-ONSET POMPE DISEASE

Source text for Eikon:  ID:nGNX9qXNvw 
Further company coverage:  FOLD.O 

 ((Reuters.Briefs@thomsonreuters.com;))